TREATMENT FOR STAGE I NONSEMINOMATOUS TESTICULAR GERM CELL TUMORS

Overall survival is about 100 % in patients with stage I testicular germ cell tumors after orchofuniculectomy, which is achieved, by applying alternative adjuvant approaches. Methods, such as a follow-up, chemotherapy or retroperitoneal lymphadenectomy, may be used to treat nonseminomatous germ cell...

Full description

Bibliographic Details
Main Authors: E. A. Burova, A. A. Bulanov, A. A. Tryakin, M. Yu. Fedyanin, V. B. Matveev, S. A. Tulandin
Format: Article
Language:Russian
Published: ABV-press 2014-07-01
Series:Onkourologiâ
Subjects:
Online Access:https://oncourology.abvpress.ru/oncur/article/view/44
id doaj-bed9b370fbef4cffb31ba35748220ed7
record_format Article
spelling doaj-bed9b370fbef4cffb31ba35748220ed72021-07-29T08:41:36ZrusABV-pressOnkourologiâ 1726-97761996-18122014-07-0171101510.17650/1726-9776-2011-7-1-10-1559TREATMENT FOR STAGE I NONSEMINOMATOUS TESTICULAR GERM CELL TUMORSE. A. Burova0A. A. Bulanov1A. A. Tryakin2M. Yu. Fedyanin3V. B. Matveev4S. A. Tulandin5Russian Cancer Research Center, Russian Academy of Medical Sciences, MoscowRussian Cancer Research Center, Russian Academy of Medical Sciences, MoscowRussian Cancer Research Center, Russian Academy of Medical Sciences, MoscowRussian Cancer Research Center, Russian Academy of Medical Sciences, MoscowRussian Cancer Research Center, Russian Academy of Medical Sciences, MoscowRussian Cancer Research Center, Russian Academy of Medical Sciences, MoscowOverall survival is about 100 % in patients with stage I testicular germ cell tumors after orchofuniculectomy, which is achieved, by applying alternative adjuvant approaches. Methods, such as a follow-up, chemotherapy or retroperitoneal lymphadenectomy, may be used to treat nonseminomatous germ cell tumors. The paper shows the main advantages and disadvantages of the above treatment options.https://oncourology.abvpress.ru/oncur/article/view/44nonseminomatous testicular germ cell tumorstreatmentfollow-upchemotherapyretroperitoneal lymphadenectomy
collection DOAJ
language Russian
format Article
sources DOAJ
author E. A. Burova
A. A. Bulanov
A. A. Tryakin
M. Yu. Fedyanin
V. B. Matveev
S. A. Tulandin
spellingShingle E. A. Burova
A. A. Bulanov
A. A. Tryakin
M. Yu. Fedyanin
V. B. Matveev
S. A. Tulandin
TREATMENT FOR STAGE I NONSEMINOMATOUS TESTICULAR GERM CELL TUMORS
Onkourologiâ
nonseminomatous testicular germ cell tumors
treatment
follow-up
chemotherapy
retroperitoneal lymphadenectomy
author_facet E. A. Burova
A. A. Bulanov
A. A. Tryakin
M. Yu. Fedyanin
V. B. Matveev
S. A. Tulandin
author_sort E. A. Burova
title TREATMENT FOR STAGE I NONSEMINOMATOUS TESTICULAR GERM CELL TUMORS
title_short TREATMENT FOR STAGE I NONSEMINOMATOUS TESTICULAR GERM CELL TUMORS
title_full TREATMENT FOR STAGE I NONSEMINOMATOUS TESTICULAR GERM CELL TUMORS
title_fullStr TREATMENT FOR STAGE I NONSEMINOMATOUS TESTICULAR GERM CELL TUMORS
title_full_unstemmed TREATMENT FOR STAGE I NONSEMINOMATOUS TESTICULAR GERM CELL TUMORS
title_sort treatment for stage i nonseminomatous testicular germ cell tumors
publisher ABV-press
series Onkourologiâ
issn 1726-9776
1996-1812
publishDate 2014-07-01
description Overall survival is about 100 % in patients with stage I testicular germ cell tumors after orchofuniculectomy, which is achieved, by applying alternative adjuvant approaches. Methods, such as a follow-up, chemotherapy or retroperitoneal lymphadenectomy, may be used to treat nonseminomatous germ cell tumors. The paper shows the main advantages and disadvantages of the above treatment options.
topic nonseminomatous testicular germ cell tumors
treatment
follow-up
chemotherapy
retroperitoneal lymphadenectomy
url https://oncourology.abvpress.ru/oncur/article/view/44
work_keys_str_mv AT eaburova treatmentforstageinonseminomatoustesticulargermcelltumors
AT aabulanov treatmentforstageinonseminomatoustesticulargermcelltumors
AT aatryakin treatmentforstageinonseminomatoustesticulargermcelltumors
AT myufedyanin treatmentforstageinonseminomatoustesticulargermcelltumors
AT vbmatveev treatmentforstageinonseminomatoustesticulargermcelltumors
AT satulandin treatmentforstageinonseminomatoustesticulargermcelltumors
_version_ 1721252723303645184